Company Profile

Fawkes Biotechnology LLC
Profile last edited on: 3/7/22      CAGE: 7PME3      UEI: PNN2MU8LSPR3

Business Identifier: Identification and treatment of concussions
Year Founded
2013
First Award
2018
Latest Award
2018
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

A 152 ASTECC Building
Lexington, KY 40506
   (601) 454-6729
   N/A
   www.fawkesbio.com
Location: Single
Congr. District: 06
County: Fayette

Public Profile

Addressing the issue of handling/ treating concussions, the principals of Fawkes Biotechnology suggest that - from a drop of blood - the firm's patented biomarker Point of Care in vitro device can determine if a concussive event has occurred within 15 minutes. Management is addressing furthering development stages with the objective of seeking FDA approval as apprpriate.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 1 NIH $197,824
Project Title: Commercialization of a Rapid Blood Test for Traumatic Brain Injury

Key People / Management

  Melissa Bradley-Whitman

  Robert Lewis

  Mark Anthony Lovell

  Bert Lynn

Company News

There are no news available.